Ajanta Pharma
AJANTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Mannalal B Agrawal · MD: Yogesh M Agrawal · Listing date: June 1, 2000 · Employees: 7035 · Mumbai · http://www.ajantapharma.com

Stock Price vs Company Growth
1d
1.6%
1w
3.4%
1m
8.3%
3m
14.3%
6m
13.3%
1y
21.8%
5y
23.3%
10y
14.3%
all
40.5%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,567 1.6%
2,452
3,115
Company Overview

Sales
4,532 Cr
Growth: 13.0%
Profit after Tax
898 Cr
Growth: 2.6%
Large Cap
32,059 Cr
P/E: 35.9x
Industry P/E: 29.8x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 4,532
Growth 13.0%
EBITDA 27.4%
P/S 7.1x
Dividend 1.7%
P/E 35.9x
Book Value ₹ 341
PEG Ratio 2.8x
ROE 22.9%
P/B 7.5x
Shareholding Pattern

Institutions
Uti Flexi Cap Fund
3.46 %
Mirae Asset Emerging Bluechip Fund
3.41 %
Sbi Magnum Global Fund
1.28 %
Llp
0.08 %
Iepf
0.06 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Mar22Dec22Jun23Sep23
Promoters
Rajesh M Agrawal, Trustee Rajesh Agrawal Trust
14.48 %
Yogesh M Agrawal, Trustee Yogesh Agrawal Trust
14.48 %
Ravi P Agrawal, Trustee Ravi Agrawal Trust
14.37 %
Aayush M Agrawal, Trustee Aayush Agrawal Trust
14.36 %
Gabs Investments Pvt Ltd
9.7 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Mar22Dec22Jun23Sep23
Others
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Mar22Dec22Jun23Sep23
Increase    Decrease    No change
Company Profile Detailed

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. Emerging markets are the major contributors in company’s branded generic business where it is present across Asia and Africa.
Investors (132)
Followers (27)